Drug Profile
C-type natriuretic peptide - Chugai Pharmaceuticals/University of Kyoto
Alternative Names: CNP analogue- Chugai Pharmaceuticals/University of KyotoLatest Information Update: 07 Nov 2021
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical; Kyoto University
- Class Cyclic peptides; Natriuretic agents; Natriuretic peptides; Recombinant proteins
- Mechanism of Action C-type natriuretic peptide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Achondroplasia
Most Recent Events
- 03 Mar 2016 Discontinued - Preclinical for Achondroplasia in Japan before March 2016 (SC)